FDA Investigator Habacuc V Barrera

Habacuc V Barrera has conducted inspections on 92 sites in 8 countries as of 27 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
92
Last Inspection Date:
27 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100007959
Countries of Inspections:
United States of America, Serbia, India, Germany, Taiwan, Spain, Argentina, France
FDA Investigators that have inspected at least one site in common with Habacuc V Barrera:
Adam C Hipko, Adrian Rodriguez, Albert F Peacock, PhD, Alcee M Tavarez, Allen F Hall, Alvaro G Dominguez, Jr, Amanda J White, Andrea A Branche, Angela Shepas, Anh M Lac, Anya Dlockett Evans, Arie R Dyk, Ashley N Williams, Audrey J Yarbrough, Benjamin K Kingsley, Bernardino E Mendez, Brackens Harris, Brian J Ryan, Camerson E Moore, Camille D Brown, Carol A Declouette Wilburn, Catherine A Spratte, Chad J Whitwell, Charles B Steinmiller, Charles D Brown, Christopher D Rush, Christopher J Hurst, Christopher J Smith, Christopher L Jacobs, Christopher T Peters, Cody J Alley, Connie L Hannon Rabel, Connie Lucero, Constance M Dobbins, Corrine M Carter, Courtney N Long, Craig A Garmendia, Cymbre Weatherly, Cynthia A Harris, MD, RN, Daniel J Lahar, Daniell Gill, Jr, Danielle Lyke, Daphne A Videau, Darla J Christopher, David M Beltran, Dawn P Hall, Debra D Devlieger, Denise Connelly, Deniza Karacic, Dina A Tallman, Ed Gonzalez Vazquez, Edwin Ramos, Elizabeth D Connell, Elizabeth P Mayer, Emily A Baldwin, Eric R Heebner, Erica Uribe, Ernest Serna, III, Fernando C Martinez, Florecia S Philogene, Francisco J Mendoza, Franklin R Harris, Frans E Mercado, Gery M Duparc, Glasgow Glasgow, H Ljamilla Selby, Hala L Selby, Huanli Liu, Hung V Le, Iris C Macinnes, J Elkins, Jacob S Foster, Jacob W Reynolds, Jamie M Bumpas, Janete F Guardia, Jasmine Y Wang, Jeffrey R Wooley, Jennifer Hua, Jennifer O Dowdy, Jeremi S Mullins, Jeremy W Rotton, Jerry E Lott, Joanne M Schlossin, Jocelyn C Turner, Joel D Martinez, Johann M Fitch, Johnson, Jonaida Estevez Martinez, Jonathan A Womack, Joy L Ramsey, Juan D Lopez, Kamara Tx, Karen C Daugherty, Kari M Johansen, Kari M Laynor, Kathleen Chmura Shaffer, Kelly D Sheppard, Kelvin R Wright, Kristi B Panzer, L Grant, Lan T Tran, Leighton Kn Gai, Lillie M Johnson, Lillie M Young, Lisa A Doyle, Lisa M Puttonen, Lloyd D Payne, Lorie S Hannappel, Luis A Salinas, Maotang Zhou, PhD, Marc R Dickens, Margaret M Annes, Mark A Guerra, Mark C Flotte, Marlena C Freeman, Mary A Millner, Mary Anne K Joseph, Massoud Motamed, Matthew R Maddox, Matthew S Mccollough, Merelynn Rhoten, Michael L Jones, Monique Rac Lester, Natasha N Livingston, Natasha N Mccants, Patricia M Jacobs, Patrick D Stone, MS, Patty P Kaewussdangkul, Paul E Frazier, Pauline N Logan, Percal Perez, Perla M Castillo, Philip M Steele, PhD, Phillip D Waldron, Phillip J Sample, Priya J Rathnam, Rafael H Ortiz, Ralph H Vocque, Rebecca Rodriguez, Rene R Ramirez, Rhonda L Dash, Robert M Tillman, Robert T Lorenz, Ronan F King, Ruth E Medcalf, Saijal P Naik, Scott B Laufenberg, Sha'tina R Alridge, Shawn E Larson, Sherrie L Krolczyk, Sonia R Peterson, Staci G Mcallister, Stephen D Brown, Stephen L Beekman, Steven L Strom, Susan C Baltzer, Tawny L Colling, Terri E Gibson, Theresa Kirkham (NMI), Thomas B Smith, Thomas J Arista, Toby Vern H Hill, Torrance J Slayton, Tracy J Washington, Travis M Beard, Tricia S Martinez, Vivian Garcia, Young M Yoon, Yvette S Montes, Zerita White

Habacuc V Barrera's Documents

Publish Date Document Type Title
February, 2013 FDA 483 Nexgen Pharma, Inc. - Form 483, 2013-02-05
January, 2023 FDA 483 Sloan W. Rush, M.D. - Form 483, 2023-01-26
February, 2024 FDA 483 Patrick Odia, MD - Form 483, 2024-02-16
June, 2023 FDA 483 Ravi Ganeshappa, M.D. - Form 483, 2023-06-30
December, 2021 FDA 483 Koriand'r Williams, M.D. - Form 483, 2022-01-31
December, 2021 EIR Koriand'r Williams, M.D. - EIR, 2021-12-22
December, 2022 FDA 483 Darrell T. Herrington, DO - Form 483, 2022-12-16
May, 2015 FDA 483 Response Blue Bell Creameries, L.P. - Form 483R, 2015-05-22
September, 2019 FDA 483 Turner Medical Inc - Form 483, 2019-09-12
November, 2023 FDA 483 Carl P. Griffin, M.D. - Form 483, 2023-11-17
August, 2022 FDA 483 Murtaza Mussaji, D.O.. - Form 483, 2022-08-16
February, 2013 EIR Nexgen Pharma, Inc. - EIR, 2013-02-05
May, 2015 FDA 483 Blue Bell Creameries, L.P. - Form 483, 2015-05-01
September, 2023 FDA 483 Daniel H. Ahn D.O. - Form 483, 2023-09-22
October, 2024 FDA 483 Haider Afzal, M.D. - Form 483, 2024-10-04
August, 2023 FDA 483 Steven Sarkisian, M.D - Form 483, 2023-08-04
November, 2024 FDA 483 Nanospectra Bioscience Inc - Form 483, 2024-11-22
July, 2025 FDA 483 Paul Schulz M.D. - Form 483, 2025-07-22
October, 2025 FDA 483 Hina Budhwani - Form 483, 2025-10-24
May, 2015 FDA 483 Response Blue Bell Creameries, L.P. - Form 483R, 2015-07-21
May, 2015 FDA 483 Response Blue Bell Creameries, L.P. - Form 483R, 2015-11-13
July, 2026 FDA 483 Debra Richardson, M.D. - Form 483, 2026-07-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more